secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001808805-25-000047
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology receives Nasdaq bid price deficiency notice; has until Oct 28, 2025 to regain compliance.
--------------------------------------------------------------------------------

- Received notice on May 1, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days through April 30, 2025.
- Has 180 calendar days (until October 28, 2025) to regain compliance; stock continues trading.
- To cure, closing bid price must be at least $1.00 for ten consecutive business days during the Compliance Period.
- If not compliant, may qualify for additional 180 days by transferring to Nasdaq Capital Market and meeting other requirements.
- No immediate delisting; company evaluating options but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000047/0001808805-25-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000047/naut-20250501.htm
  HTML page:      https://secwatch.observer/filing/0001808805-25-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer